Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Apollo Endosurgery, Inc. (APEN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.9200-0.0600 (-1.51%)
At close: 04:00PM EDT
Advertisement

Apollo Endosurgery, Inc.

Building 1
Suite 300 1120 South Capital of Texas Highway
Austin, TX 78746
United States
512 279 5100
https://www.apolloendo.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees202

Key Executives

NameTitlePayExercisedYear Born
Mr. Charles S. McKhannCEO, Pres & Director963.53kN/A1969
Mr. Jeffrey G. BlackCFO, Sec. & Treasurer524.02kN/A1969
Mr. John J. MolesphiniExec. VP of Operations502.58kN/A1958
Dr. Sergey Kantsevoy M.D.Co-Founder and Innovation PartnerN/AN/AN/A
Mr. Anthony Kalloo M.D.Co-Founder and Innovation PartnerN/AN/AN/A
Dr. Robert Hawes M.D.Co-Founder and Innovation PartnerN/AN/AN/A
Dr. Peter Benjamin Cotton M.D.Co-Founder and Innovation PartnerN/AN/AN/A
Dr. Christopher J. Gostout M.D.Co-Founder & Chief Medical OfficerN/AN/A1951
Mr. Sydney Chung M.D.Co-Founder and Innovation PartnerN/AN/AN/A
Dr. Pankaj Jay Pasricha FACP, M.D., MBBSCo-FounderN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Corporate Governance

Apollo Endosurgery, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement